Leaflet: information for the user
Meloxicam Normon 7.5 mg tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
1. What isMeloxicam Normonand what it is used for
2. What you need to know before starting to takeMeloxicam Normon
3. How to takeMeloxicam Normon
4. Possible side effects
5. Storage ofMeloxicam Normon
6. Contents of the pack and additional information
Meloxicambelongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) used to reduce inflammation and pain in joints and muscles.
Meloxicam Normon is indicated in adults and children 16 years of age and older, for:
Do not takeMeloxicam Normon:
If you are unsure about any of the above situations, please contact your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Meloxicam Normon.
If you have ever had a fixed drug eruption (flat, oval-shaped patches with redness and swelling of the skin that usually reappear in the same place, blistering, urticaria, and itching) after taking meloxicam or other oxicam derivatives (e.g., piroxicam).
Warnings
Meloxicam Normon may be associated with a slight increase in the risk of heart attack ("myocardial infarction") or stroke ("cerebral infarction"). Any risk is greater at high doses and with prolonged treatment.
Do not take more than the recommended dose. Do not take Meloxicam Normon for longer than prescribed (see section 3 "How to take Meloxicam Normon").
If you have heart problems, a previous stroke, or if you think you may be at risk of these diseases, you should discuss treatment with your doctor or pharmacist.
For example, if you:
- have high blood pressure (hypertension).
- have high blood sugar (diabetes mellitus).
- have high cholesterol levels in the blood (hypercholesterolemia).
- are a smoker.
Stop taking Meloxicam Normon immediately as soon as you notice bleeding (causing black stools) or ulcers in your digestive tract (causing abdominal pain).
Severe skin reactions that can be life-threatening (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been described with the use of meloxicam, appearing initially as red, circular spots, often with a central blister. Other additional signs that may appear are mouth sores, throat, nose, genital, and conjunctivitis (swollen, red eyes). These life-threatening skin reactions often occur with flu-like symptoms. The skin reaction may progress to form widespread blisters or skin peeling. The period of highest risk of developing severe skin reactions is during the first weeks of treatment. If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with meloxicam, you should not use meloxicam again at any time.
If you develop a rash or these symptoms on your skin, stop taking meloxicam, go to a doctor immediately, and inform them that you are taking this medicine.
Meloxicam Normon is not suitable if you need to relieve acute pain immediately.
Meloxicam Normon may mask the symptoms of an infection (e.g., fever). If you think you may have an infection, you should see a doctor.
Precautions for use
As treatment will need to be adjusted, it is essential to seek advice from your doctor before taking Meloxicam Normon in the following situations:
Your doctor will need to monitor your progress during treatment.
Taking Meloxicam Normon with other medicines
As Meloxicam Normon may affect or be affected by other medicines, inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Specifically, please inform your doctor or pharmacist if you are taking/have taken or have used any of the following medicines:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy:
You should not take meloxicam during the first 6 months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time. From week 20 of pregnancy, meloxicam may cause kidney problems in your fetus if taken for more than a few days, which may lead to low amniotic fluid levels surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
During the last 3 months of pregnancy, this medicine is contraindicated: NEVER take this medicine because it may have serious or even fatal consequences for your fetus/child, especially for their heart, lungs, and/or kidneys, even with a single administration. Do not take meloxicam if you are in the last 3 months of pregnancy, as it may harm your fetus or cause problems during delivery. It may cause kidney and heart problems in your fetus. It may affect your predisposition and that of your baby to bleed and delay or prolong delivery more than expected.
If you have taken this medicine while pregnant, you should speak to your doctor/midwife immediately so that they can consider adequate monitoring.
Breastfeeding:
This medicine is not recommended during breastfeeding.
Fertility:
This medicine may make it more difficult for you to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have difficulty becoming pregnant.
Driving and operating machinery
This medicine may cause visual disturbances, including blurred vision, dizziness, drowsiness, vertigo, or other central nervous system disturbances. If you notice these effects, do not drive or operate machinery.
Meloxicam Normon contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Arthritis crisis (osteoarthritis):
7.5 mg (one tablet) once a day. This can be increased to 15 mg (two tablets) once a day.
Rheumatoid arthritis:
15 mg (two tablets) once a day. This can be reduced to 7.5 mg (one tablet) once a day.
Ankylosing spondylitis:
15 mg (two tablets) once a day. This can be reduced to 7.5 mg (one tablet) once a day.
Do not exceed the maximum recommended dose of 15 mg per day.
If any of the situations described under the title “Warnings and precautions” affect you, your doctor may limit your dose to 7.5 mg (one tablet) once a day.
Older patients
If you are an elderly person, the recommended dose in long-term treatment for rheumatoid arthritis and ankylosing spondylitis is 7.5 mg (one tablet) once a day.
Patients at increased risk of adverse reactions
If you are a patient at increased risk of adverse reactions, your doctor will start treatment at a dose of 7.5 mg (one tablet) per day.
Renal insufficiency
If you are a patient on dialysis with severe renal insufficiency, your dose should not exceed 7.5 mg (one tablet) per day. In patients with mild to moderate renal insufficiency, dose reduction is not necessary.
Liver insufficiency
In patients with mild to moderate liver insufficiency, dose reduction is not necessary.
Use in children and adolescents
Meloxicam Normon should not be administered to children and adolescents under 16 years old.
Consult your doctor or pharmacist if you estimate that the action of Meloxicam Normon is too strong or too weak, or if after several days you do not notice any improvement.
Administration form:
Oral route.
The tablets should be swallowed with water or another beverage during meals.
The tablet can be divided into equal doses.
If you take moreMeloxicam Normon than you should
If you have taken too many tablets or suspect an overdose, contact your doctor or go to the nearest hospital immediately.
The symptoms associated with acute overdose of NSAIDs are usually limited to:
These symptoms usually improve when Meloxicam Normon is stopped.Gastrointestinal bleeding may occur.
Severe intoxication may cause severe adverse reactions (see section 4):
- high blood pressure (hypertension)
- acute kidney failure (renal failure)
- liver dysfunction (hepatic dysfunction)
- respiratory depression (respiratory depression)
- loss of consciousness (coma)
- seizures (convulsions)
- cardiovascular collapse (cardiovascular collapse)
- cardiac arrest (cardiac arrest)
- immediate allergic reactions (hypersensitivity), including:
- fainting
- shortness of breath
- skin reactions
If you forget to takeMeloxicam Normon
Do not take a double dose to compensate for the missed doses.Simply take the next dose at the usual time.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Meloxicam Normon can cause side effects, although not everyone will experience them.
Stop taking Meloxicam Normon and consult your doctor or the nearest hospital immediately if you notice:
Any allergic reaction (hypersensitivity) that may appear in the form of:
Erythema multiforme is a severe skin allergic reaction that causes patches, red rashes or purple areas with blisters. It can also affect the mouth, eyes, and other moist areas of the body.
-yellowing of the skin and eyes (jaundice)
-abdominal pain
-loss of appetite
Any gastrointestinal side effect, especially:
Bleeding in the digestive tract (gastrointestinal hemorrhage), ulcer formation or a hole in the digestive tract (perforation) can sometimes be severe and potentially life-threatening, especially in older people.
If you have previously experienced any gastrointestinal symptoms due to prolonged use of NSAIDs, seek medical advice immediately, especially if you are an elderly person. Your doctor may monitor your progress while you are on treatment.
If you experience vision changes, do not drive or use machines.
Side effectsof nonsteroidal anti-inflammatory drugs (NSAIDs)
The use of some NSAIDs may be associated with a slight increase in the risk of arterial occlusion (arterial thrombotic events), such as heart attack (myocardial infarction) or stroke (apoplexy), particularly at high doses and with long-term treatment.
Cases of fluid retention (edema), high blood pressure (hypertension), and heart failure (cardiac failure) have been reported associated with NSAID treatment.
The most commonly observed side effects affect the gastrointestinal tract (gastrointestinal events):
- stomach and upper small intestine ulcers (peptic/gastroduodenal ulcers)
- a hole in the intestinal wall (perforation) or bleeding in the digestive tract (sometimes fatal, especially in older people)
After NSAID administration, the following side effects have been reported:
- nausea and vomiting
- loose stools (diarrhea)
- flatulence
- constipation
- indigestion (dyspepsia)
- abdominal pain
- black stools due to bleeding in the digestive tract (melena)
- vomiting blood (hematemesis)
- inflammation with ulcer formation in the mouth (ulcerative stomatitis)
- worsening of gastrointestinal inflammation (e.g. exacerbation of colitis or Crohn's disease)
Less frequently, stomach inflammation (gastritis) has been observed.
Meloxicam side effects
Very common side effects: can affect more than 1 in 10 people
Gastrointestinal side effects such as indigestion (dyspepsia), nausea and vomiting, abdominal pain, constipation, flatulence, and loose stools (diarrhea)
Common side effects: can affect up to 1 in 10 people
Headache
Rare side effects: can affect up to 1 in 100 people
Rare side effects: can affect up to 1 in 1,000 people
These side effects can increase the risk of infection and cause symptoms such as bruises or nosebleeds.
Very rare side effects: can affect up to 1 in 10,000 people
Multiform erythema is a severe skin allergic reaction that causes patches, red rashes or purple areas with blisters. It can also affect the mouth, eyes, and other moist areas of the body.
Side effects of unknown frequency: the frequency cannot be estimated from the available data
Side effects caused by other nonsteroidal anti-inflammatory drugs (NSAIDs) that have not been seen after taking Meloxicam Normon
Changes in kidney structure that cause acute kidney failure:
protein in the urine (nephrotic syndrome with proteinuria)
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required.
Do not usethis medicationafter the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash.Deposit the packaging and medicines you no longer need at the SIGRE collection pointof the pharmacy. Please ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition ofMeloxicam Normon
The active ingredient is meloxicam. Each tablet contains 7.5 mg of meloxicam
The other components (excipients) are: sodium citrate, microcrystalline cellulose (E460), lactose monohydrate, povidone, anhydrous colloidal silica, magnesium stearate, carboxymethylcellulose sodium type A (from potato).
Appearance of the product and content of the packaging
Meloxicam Normon 7.5 mg tablets are presented in the form of cylindrical, biconvex, scored, yellow tablets. The tablet can be divided into equal doses.
Each package contains 20 tablets.
Holder of the marketing authorization and responsible for manufacturing
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo 6,
28760 Tres Cantos, Madrid (Spain)
Other presentations
Meloxicam Normon 15 mg tablets EFG
Last review date of this leaflet:June 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.